GlassScriptPhysician profile
Srinivas Gaddam
NPI 1982815262
$3,340.63
in general payments reported to CMS, 2019-2025
7 companies · $2,837 in 2025
The $2,837 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.74 · 2021: $69.53 · 2023: $201 · 2024: $205 · 2025: $2,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,300 · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,300.00 |
| Food and Beverage | $942.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,497.81 | 2020-2025 | Clinical Trial Product |
| Fujifilm Healthcare Americas Corporation | $375.27 | 2024-2025 | Fujifilm |
| Medtronic, INC. | $208.81 | 2023-2024 | Prodigi, Nexpowder |
| Conmed Corporation | $133.99 | 2025 | Conmed Generators, Conmed Biliary |
| Cook Medical LLC | $94.37 | 2025 | Echotip Insight |
| Olympus America INC. | $30.38 | 2024 | Evis Eus Endoscopic Ultrasound Center |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Gaddam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.